A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer.

Saved in:
Bibliographic Details
Title: A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer.
Authors: Clemons, M.1,2,3 mclemons@toh.ca, Fergusson, D.3,4, Simos, D.5, Mates, M.6, Robinson, A.6, Califaretti, N.7, Zibdawi, L.5, Bahl, M.7, Raphael, J.8,9, Ibrahim, M.F.K.10, Fernandes, R.8, Pitre, L.11, Aseyev, O.10, Stober, C.2, Vandermeer, L.2, Saunders, D.2, Hutton, B.3, Mallick, R.3, Pond, G.R.12, Awan, A.1
Source: Annals of Oncology. Jul2020, Vol. 31 Issue 7, p951-957. 7p. 1 Diagram, 3 Charts.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.04.005